hrp0095p1-131 | Growth and Syndromes | ESPE2022

SHORT syndrome in a twelve-year old boy-case report

Priakou Syraina , Smyrnaki Pinelopi , Giatzakis Christoforos , Xekouki Paraskevi , Stratakis Constantine

Background: “SHORT syndrome” is a rare condition and mnemonic for Short stature, Hyperextensibility, Ocular depression, Rieger anomaly and Teething delay. The features most consistently observed in SHORT syndrome are mild intrauterine growth restriction; mild to moderate short stature; partial lipodystrophy; and a characteristic facial gestalt (small chin, triangular shaped face, prominent forehand, abnormal positioning large ears and thin wrinkled...

hrp0097p1-156 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

A novel ROBO1 gene variant in a patient with pituitary stalk interruption and multiple congenital anomalies

Nioti Olga , Smyrnaki Pinelopi , Giatzakis Christoforos , Xekouki Paraskevi , Stratakis Constantine

Background: Pituitary stalk interruption syndrome is a rare disorder characterized by an absent or ectopic posterior pituitary, anterior pituitary hypoplasia and an interrupted pituitary stalk. In some cases, a variety of additional congenital defects may be present. A genetic cause is identified in only around 5% of all cases.Case presentation: A 13-year-old male presented to the pediatric endocrinology clinic because o...

hrp0098fc4.6 | Adrenals and HPA Axis 1 | ESPE2024

Comparative Efficacy of Modified-Release versus Conventional Hydrocortisone Treatment in Adolescents and Young Adults with Congenital Adrenal Hyperplasia: A Retrospective Observational Study

Smirnaki Pinelopi , Karantza Maria , Mavraki Lydia , Xekouki Paraskevi

Introduction and Purpose: Congenital Adrenal Hyperplasia (CAH) encompasses a group of genetic disorders arising from enzyme deficiencies crucial for the biosynthesis of cortisol and mineralocorticoids, resulting in decreased cortisol and increased androgen production. Standard treatment involves oral hydrocortisone administration 2-3 times daily. However, this treatment often fails to mimic the circadian rhythm and effectively suppress androgen production, esp...

hrp0098p2-157 | GH and IGFs | ESPE2024

Investigation of Short Stature in a 10-Year-Old Girl with STAT3 Gain-of-Function Syndrome

Mavraki Lydia , Smirnaki Pinelopi , Xekouki Paraskevi , Stratakis Konstantinos

Introduction and Purpose: STAT3 gain-of-function (GOF) syndrome is a rare monogenic autosomal dominant disease, caused by activating mutations in the STAT3 gene encoding the STAT3 protein, which is involved in the signal transduction pathway. Disruption of STAT3 structure leads to an early-onset multi-organ disease, characterized by lymphoproliferation, autoimmune cytopenias and growth retardation. Treatment includes immunosuppression, immunotherapy and alloge...

hrp0098p1-290 | Thyroid 3 | ESPE2024

A Retrospective Observational Study of Patients with Differentiated Thyroid Cancer from a Pediatric Endocrinology Clinic in Crete

Smirnaki Pinelopi , Mavraki Lydia , Dimakis Efthimios , Drakonaki Eleni , Koukouraki Sofia , Kapsoritakis Nikolaos , Xekouki Paraskevi

Introduction and Purpose: Differentiated thyroid cancer in children is rare. However, its incidence has increased recently. It differs from adult thyroid cancer in terms of clinical, molecular and pathologic features. Pediatric patients present with advanced disease at the time of diagnosis. They have an excellent prognosis and a 5-year survival rate that reaches 100%. The aim of this study was to record and statistically analyze data from children diagnosed w...

hrp0092p3-192 | Pituitary, Neuroendocrinology and Puberty | ESPE2019

Rohhad Syndrome: Report of 2 Rare Cases From Crete-Greece

Smyrnaki Pinelopi , Chrysoulaki Maria , Daraki Vasiliki , Betsi Grigoria , Sfakiotaki Maria , Floroskoufi Paraskevi , Bouki Katerina , Kofteridis Diamandis , Kanaka-Gantenbein Christina , Xekouki Paraskevi

Introduction: ROHHAD syndrome (Rapid-onset Obesity with Hypoventilation, hypothalamic and autonomic dysregulation) is a rare and complex disease with potential fatal outcome. To this day there have been 158 cases reported in the literature while whole exome sequencing has not yet revealed any responsible genes. It usually presents at the age of 2-4 years and the diagnosis is based on the following criteria: 1) rapidly progressive obesity that develops at the a...